STERIS plc (NYSE:STE) Receives $273.50 Average PT from Brokerages

Shares of STERIS plc (NYSE:STE) have received a consensus recommendation of “Moderate Buy” from the nine analysts that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $273.50.

Separately, Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th.

STERIS Trading Up 0.4%

Shares of STERIS stock opened at $262.81 on Wednesday. The firm has a 50-day simple moving average of $259.30 and a two-hundred day simple moving average of $248.61. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.63 and a current ratio of 2.37. STERIS has a fifty-two week low of $204.90 and a fifty-two week high of $269.44. The company has a market cap of $25.79 billion, a P/E ratio of 37.76 and a beta of 1.03.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.09. STERIS had a net margin of 12.07% and a return on equity of 14.43%. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the firm earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities analysts predict that STERIS will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Tuesday, February 17th will be issued a $0.63 dividend. This represents a $2.52 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Tuesday, February 17th. STERIS’s dividend payout ratio is 36.21%.

Insider Buying and Selling

In other STERIS news, VP Julia Madsen sold 5,008 shares of STERIS stock in a transaction on Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the transaction, the vice president directly owned 10,710 shares in the company, valued at approximately $2,806,020. The trade was a 31.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total value of $3,977,100.00. Following the completion of the transaction, the vice president owned 33,669 shares in the company, valued at $8,926,998.66. This trade represents a 30.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 25,044 shares of company stock worth $6,586,218 over the last 90 days. 1.07% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Steigerwald Gordon & Koch Inc. acquired a new stake in shares of STERIS in the third quarter valued at about $25,000. Board of the Pension Protection Fund acquired a new position in STERIS during the 4th quarter worth approximately $25,000. Harbor Investment Advisory LLC boosted its holdings in STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 60 shares during the period. Activest Wealth Management grew its position in STERIS by 423.8% in the fourth quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 89 shares in the last quarter. Finally, Spurstone Advisory Services LLC purchased a new stake in shares of STERIS during the second quarter valued at approximately $29,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.